Molina Healthcare Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Joe Zubretsky
Algemeen directeur
US$21.5m
Totale compensatie
| Percentage CEO-salaris | 7.0% |
| Dienstverband CEO | 7yrs |
| Eigendom CEO | 0.6% |
| Management gemiddelde ambtstermijn | 6yrs |
| Gemiddelde ambtstermijn bestuur | 9.3yrs |
Recente managementupdates
Recent updates
Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results
Oct 27
Molina Healthcare Q3 Earnings Preview - Cost Fears Flare Up
Oct 18Returns On Capital Signal Tricky Times Ahead For Molina Healthcare (NYSE:MOH)
Oct 10Are Investors Undervaluing Molina Healthcare, Inc. (NYSE:MOH) By 48%?
Sep 11Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?
Aug 15Molina Healthcare: Health Insurer Selling For A Discount
Jul 25Molina Healthcare, Inc.'s (NYSE:MOH) Subdued P/E Might Signal An Opportunity
Jul 16Molina Healthcare (NYSE:MOH) Is Reinvesting At Lower Rates Of Return
May 27Molina Healthcare: Stock To Rise As Strategies Drive Strong Future Growth
May 06Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%
Apr 26Molina Healthcare (NYSE:MOH) Seems To Use Debt Rather Sparingly
Apr 15Molina Healthcare, Inc.'s (NYSE:MOH) Popularity With Investors Is Clear
Apr 01Should You Be Adding Molina Healthcare (NYSE:MOH) To Your Watchlist Today?
Mar 18An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 35% Undervalued
Mar 04Molina Healthcare: Attractive Risk-Reward Calculus Over All Horizons
Jan 26Molina Healthcare (NYSE:MOH) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16Does Molina Healthcare (NYSE:MOH) Have A Healthy Balance Sheet?
Jan 02Investors Still Waiting For A Pull Back In Molina Healthcare, Inc. (NYSE:MOH)
Dec 20Here's Why We Think Molina Healthcare (NYSE:MOH) Might Deserve Your Attention Today
Dec 06An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 46% Undervalued
Nov 08Molina Healthcare Q3: Robust Growth Potential Yet Underrated Compared To Peers
Oct 30Shareholders Are Optimistic That Molina Healthcare (NYSE:MOH) Will Multiply In Value
Oct 11Molina Healthcare: Stable State Governments Contracts, And Undervalued
Sep 11We Think Molina Healthcare (NYSE:MOH) Can Manage Its Debt With Ease
Sep 08Here's Why Molina Healthcare (NYSE:MOH) Has Caught The Eye Of Investors
Aug 21Molina Healthcare: A Hidden Compounder In Managed Healthcare
Jul 17Investors Shouldn't Overlook Molina Healthcare's (NYSE:MOH) Impressive Returns On Capital
Jul 09Is There An Opportunity With Molina Healthcare, Inc.'s (NYSE:MOH) 43% Undervaluation?
May 29Here's Why We Think Molina Healthcare (NYSE:MOH) Is Well Worth Watching
May 15Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet
May 01We Think Molina Healthcare (NYSE:MOH) Might Have The DNA Of A Multi-Bagger
Mar 31Molina Healthcare Is Still Appealing In The Face Of Medicaid Redetermination
Feb 21Is Now The Time To Put Molina Healthcare (NYSE:MOH) On Your Watchlist?
Feb 13Molina Healthcare Non-GAAP EPS of $4.10 beats by $0.08, revenue of $8.22B beats by $350M
Feb 08Molina Healthcare (NYSE:MOH) Could Easily Take On More Debt
Jan 29Molina Healthcare takes $200M impairment on its leased space
Dec 29Molina Healthcare (NYSE:MOH) Could Become A Multi-Bagger
Nov 23Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet
Oct 25Molina Healthcare: Sacrificing Dividend For Growth Can Pay Off
Oct 20Molina initiated at overweight at JP Morgan on recent Medicaid contracts
Oct 04When Should You Buy Molina Healthcare, Inc. (NYSE:MOH)?
Sep 26Molina Healthcare of New Mexico partners with Pyx Health
Sep 13Molina Healthcare reaches 52-week high; up 29% over last year
Aug 26A Look At The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)
Aug 17Why The 22% Return On Capital At Molina Healthcare (NYSE:MOH) Should Have Your Attention
Aug 04Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | n/a | n/a | US$1b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$21m | US$2m | US$1b |
| Sep 30 2023 | n/a | n/a | US$931m |
| Jun 30 2023 | n/a | n/a | US$916m |
| Mar 31 2023 | n/a | n/a | US$855m |
| Dec 31 2022 | US$22m | US$2m | US$792m |
| Sep 30 2022 | n/a | n/a | US$839m |
| Jun 30 2022 | n/a | n/a | US$752m |
| Mar 31 2022 | n/a | n/a | US$689m |
| Dec 31 2021 | US$20m | US$2m | US$659m |
| Sep 30 2021 | n/a | n/a | US$590m |
| Jun 30 2021 | n/a | n/a | US$632m |
| Mar 31 2021 | n/a | n/a | US$723m |
| Dec 31 2020 | US$18m | US$1m | US$673m |
| Sep 30 2020 | n/a | n/a | US$807m |
| Jun 30 2020 | n/a | n/a | US$797m |
| Mar 31 2020 | n/a | n/a | US$717m |
| Dec 31 2019 | US$18m | US$1m | US$737m |
| Sep 30 2019 | n/a | n/a | US$770m |
| Jun 30 2019 | n/a | n/a | US$792m |
| Mar 31 2019 | n/a | n/a | US$798m |
| Dec 31 2018 | US$15m | US$1m | US$707m |
| Sep 30 2018 | n/a | n/a | US$244m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$482m |
| Dec 31 2017 | US$20m | US$175k | -US$512m |
Compensatie versus markt: De totale vergoeding ($USD 21.49M ) Joe } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.73M ).
Compensatie versus inkomsten: De vergoeding van Joe is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Joe Zubretsky (67 yo)
7yrs
Tenure
US$21,491,723
Compensatie
Mr. Joseph Michael Zubretsky, also known as Joe, has been President, Chief Executive Officer and Director of Molina Healthcare, Inc. since November 6, 2017. Mr. Zubretsky served as President and Chief Exec...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 7yrs | US$21.49m | 0.61% $ 118.2m | |
| Senior EVP | 3.8yrs | US$6.40m | 0.083% $ 16.1m | |
| Senior EVP & COO | 1.5yrs | US$5.54m | 0.094% $ 18.1m | |
| Chief Accounting Officer | 6.2yrs | US$1.27m | 0.017% $ 3.2m | |
| Chief Legal Officer & Corporate Secretary | 14.3yrs | US$4.89m | 0.12% $ 22.3m | |
| Head of Investor Relations | no data | geen gegevens | geen gegevens | |
| Vice President of Compliance | 18.3yrs | geen gegevens | geen gegevens | |
| Executive VP & Chief Human Resources Officer | 5.8yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer | 10.3yrs | geen gegevens | geen gegevens | |
| Chief Operating Officer of Molina Healthcare of California | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Health Plans | 4.8yrs | geen gegevens | geen gegevens | |
| Executive VP of Marketplace & Chief Medical Officer | 4.8yrs | geen gegevens | geen gegevens |
6.0yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van MOH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 7yrs | US$21.49m | 0.61% $ 118.2m | |
| Independent Non-Executive Chairman of the Board | 11.7yrs | US$545.46k | 0.027% $ 5.2m | |
| Independent Director | 11.7yrs | US$342.96k | 0.011% $ 2.1m | |
| Independent Director | 19yrs | US$380.46k | 0.034% $ 6.6m | |
| Independent Vice Chair of the Board | 21.8yrs | US$385.46k | 0.030% $ 5.8m | |
| Independent Director | 5.5yrs | US$347.96k | 0.0071% $ 1.4m | |
| Independent Director | 6.3yrs | US$347.96k | 0.012% $ 2.3m | |
| Independent Director | 3.5yrs | US$332.96k | 0.0046% $ 878.9k | |
| Independent Director | 9.3yrs | US$357.96k | 0.020% $ 3.9m |
9.3yrs
Gemiddelde duur
68yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van MOH wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.3 jaar).